Skip to content

SCHEDULE 13D/AAccepted Jan 9, 4:19 PM ET

Monte Rosa Therapeutics, Inc. SCHEDULE 13D/A

Versant Venture Capital VI, L.P.

Accepted (ET)

4:19 PM

Jan 9, 2026

Filed

Jan 9, 2026

Documents

1

Size

18.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.